Investing.com - Benitec Biopharma ADR (NASDAQ: BNTC) reported third quarter EPS of $-0.160, $0.04 better than the analyst estimate of $-0.200. Revenue for the quarter came in at $54K versus the consensus estimate of $0.00.
Benitec Biopharma ADR's stock price closed at $0.210. It is down -6.960% in the last 3 months and down -80.190% in the last 12 months.
Benitec Biopharma ADR saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Benitec Biopharma ADR's stock price’s past reactions to earnings here.
According to InvestingPro, Benitec Biopharma ADR's Financial Health score is "weak performance".
Check out Benitec Biopharma ADR's recent earnings performance, and Benitec Biopharma ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar